| Alternatives to testosterone therapy: a review EM Lo, KM Rodriguez, AW Pastuszak, M Khera Sexual medicine reviews 6 (1), 106-113, 2018 | 65 | 2018 |
| Connexin 36 and rod bipolar cell independent rod pathways drive retinal ganglion cells and optokinetic reflexes CS Cowan, M Abd-El-Barr, M van der Heijden, EM Lo, D Paul, ... Vision research 119, 99-109, 2016 | 28 | 2016 |
| Penile prosthesis biofilm formation and emerging therapies against them AS Herati, EM Lo Translational Andrology and Urology 7 (6), 960, 2018 | 21 | 2018 |
| Inhibition of cyclin dependent kinase 4/6 overcomes primary resistance to programmed cell death 1 blockade in malignant mesothelioma HJ Jang, CY Truong, EM Lo, HM Holmes, D Ramos, M Ramineni, JS Lee, ... The Annals of thoracic surgery 114 (5), 1842-1852, 2022 | 19 | 2022 |
| Cholesterol-lowering intervention decreases mTOR complex 2 signaling and enhances antitumor immunity Y Wang, S You, S Su, A Yeon, EM Lo, S Kim, JL Mohler, MR Freeman, ... Clinical Cancer Research 28 (2), 414-424, 2022 | 18 | 2022 |
| Optimal endocrine evaluation and treatment of male infertility SC McGriff, EM Lo, JM Hotaling, AW Pastuszak Urologic Clinics 47 (2), 139-146, 2020 | 12 | 2020 |
| Povidone-iodine results in rapid killing of thymic epithelial tumour cells through cellular fixation HS Lee, HJ Jang, EM Lo, CY Truong, SS Groth, JS Friedberg, ... Interactive CardioVascular and Thoracic Surgery 28 (3), 353-359, 2019 | 11 | 2019 |
| Syngeneic murine model for prostate cancer using RM1 cells transfected with gp100 A Yeon, Y Wang, S Su, EM Lo, HL Kim The Prostate 80 (5), 424-431, 2020 | 7 | 2020 |
| Urologic conditions associated with malignancy EM Lo, JM Hotaling, AW Pastuszak Urologic Oncology: Seminars and Original Investigations 38 (1), 23-30, 2020 | 7 | 2020 |
| Risk factors for surgical shunting in a large cohort with ischemic priapism H Zhao, K Dallas, J Masterson, E Lo, J Houman, C Berdahl, J Pevnick, ... The journal of sexual medicine 17 (12), 2472-2477, 2020 | 6 | 2020 |
| Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone> 300 ng/dL V Madhusoodanan, P Patel, TFN Lima, J Gondokusumo, E Lo, ... International braz j urol 45, 1008-1012, 2019 | 6 | 2019 |
| Is treatment of hypogonadism safe for men after a solid organ transplant? Results from a retrospective controlled cohort study N Thirumavalavan, JM Scovell, E Lo, J Gondokusomo, M Khera, ... International Journal of Impotence Research 34 (1), 50-54, 2022 | 4 | 2022 |
| Robot-assisted surgery for upper tract urothelial carcinoma EM Lo, HL Kim Urologic Clinics 48 (1), 71-80, 2021 | 3 | 2021 |
| An analysis of stated insurance coverage and estimated patient-incurred costs of treatments for lower urinary tract symptoms N Khalfay, E Lo, T Grisales, AL Ackerman Urogynecology 29 (2), 287-294, 2023 | 2 | 2023 |
| Bipolar Androgen Therapy in Prostate Cancer (Update) EM Lo, A Balasubramanian, AW Pastuszak, M Khera The Journal of Sexual Medicine 17 (5), 831-834, 2020 | 2 | 2020 |
| MP73-09 ASSESSING SKILL ACQUISITION BETWEEN DOMINANT VERSUS NONDOMINANT HANDS IN ROBOTIC SURGERY TN Chu, EY Wong, R Ma, CH Yang, I Dalieh, E Lo, A Malpani, S Cen, ... The Journal of Urology 211 (5S), e1185, 2024 | | 2024 |
| MP73-18 SHOW AND TELL: DOES INTRAOPERATIVE FEEDBACK TYPE AFFECT TRAINEE PERFORMANCE DURING ROBOTIC SUTURING? JE Knudsen, EY Wong, R Ma, TN Chu, E Lo, E Dadashian, S Cen, ... Journal of Urology 211 (5S), e1189, 2024 | | 2024 |
| PD35-12 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION INCREASES LYMPHOCYTE INFILTRATION AND INDUCES IMMUNOGENIC CELL DEATH IN MOUSE PROSTATE CANCER S Su, Y Wang, EM Lo, P Tamukong, HL Kim Journal of Urology 211 (5S), e729, 2024 | | 2024 |
| High-intensity focused ultrasound ablation increases tumor specific lymphocytes in prostate cancer S Su, Y Wang, EM Lo, HL Kim Cancer Research 84 (6_Supplement), 3845-3845, 2024 | | 2024 |
| High-intensity focused ultrasound ablation increases lymphocyte infiltration in mouse prostate tumor S Su, Y Wang, EM Lo, P Tamukong, HL Kim The Journal of Immunology 210 (1_Supplement), 245.17-245.17, 2023 | | 2023 |
